Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Genetic Determinants of Disease Progression and Response to Sacubitril/Valsartan vs Lifestyle (Physical Activity and Dietary Nitrate) in Patients With Hypertrophic Cardiomyopathy

NCT03832660 is registered in ClinicalTrials.gov with Newcastle University as lead sponsor.

NCT NCT03832660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03832660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Genetic Determinants of Disease Progression and Response to Sacubitril/Valsartan vs Lifestyle (Physical Activity and Dietary Nitrate) in Patients With Hypertrophic Cardiomyopathy
Lead sponsor
Newcastle University
Phase
Phase 2
Overall status
Completed
Start date
May 3, 2019
Completion date
June 30, 2022
Enrollment
168 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy